Onconova Therapeutics, Inc. (ONTX)
(Delayed Data from NSDQ)
$4.07 USD
0.00 (0.00%)
Updated May 3, 2019 04:00 PM ET
After-Market: $4.16 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For ONTX
-
Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results
-
Onconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Results
-
Onconova Therapeutics, Inc. (ONTX) Reports Q1 Loss, Misses Revenue Estimates
-
Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
-
Onconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates
-
Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update
-
Onconova Therapeutics, Inc. (ONTX) Reports Q2 Loss, Lags Revenue Estimates
-
Onconova (ONTX) to Report Q1 Earnings: What's in the Cards?
-
Onconova Therapeutics, Inc. (ONTX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Onconova Therapeutics, Inc. (ONTX) Reports Q2 Loss, Tops Revenue Estimates
-
Will Onconova Therapeutics, Inc. (ONTX) Report Negative Q2 Earnings? What You Should Know
-
Onconova Therapeutics, Inc. (ONTX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Onconova (ONTX) to Report Q2 Earnings: What's in the Offing?
-
Onconova (ONTX) to Report Q4 Earnings: What's in Store?
-
Onconova Therapeutics (ONTX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Onconova Therapeutics (ONTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Will Onconova Therapeutics (ONTX) Report Negative Earnings Next Week? What You Should Know